Physician profile
David A Kostick
NPI 1336139187
$107,918.06
in general payments reported to CMS, 2019-2025
16 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,872 · 2020: $7,019 · 2021: $12K · 2022: $27K · 2023: $18K · 2024: $24K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Honoraria: $15K · Consulting Fee: $3,825 · Food and Beverage: $3,743 · Travel and Lodging: $3,686 · Education: $10.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,050.00 |
| Honoraria | $14,837.50 |
| Consulting Fee | $3,825.00 |
| Food and Beverage | $3,742.70 |
| Travel and Lodging | $3,685.85 |
| Education | $10.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $70,198.56 | 2019-2023 | Tepezza |
| Amgen INC. | $36,301.32 | 2024-2025 | Tepezza |
| Sight Sciences, INC. | $313.75 | 2019-2025 | Omni Surgical System |
| Alcon Vision LLC | $231.35 | 2019-2025 | Luxor, Ngenuity |
| Allergan, INC. | $200.00 | 2021 | |
| Kala Pharmaceuticals, INC. | $190.91 | 2019 | |
| Merz North America, INC. | $114.92 | 2019 | |
| Rxsight INC | $107.14 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Johnson & Johnson Surgical Vision, INC. | $66.45 | 2022 | |
| Abbvie INC. | $43.70 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $32.35 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $29.80 | 2025 | Purified Cortrophin Gel |
| Stryker Corporation | $26.02 | 2020 | |
| Aerie Pharmaceuticals, INC. | $23.34 | 2020 | |
| Ivantis, INC | $21.09 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $17.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kostick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.